Product
Placebo + MTX
1 clinical trial
1 indication
Indication
Rheumatoid ArthritisClinical trial
A Phase III Study of RC18,a Recombinant Human B Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein in Subjects With Poor Efficacy of MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.Status: Completed, Estimated PCD: 2022-11-19